• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Recent advances in the diagnostic evaluation of pancreatic cystic lesions

    2022-03-16 06:22:20DevarshiArdeshnaTroyCaoBrandonRodgersChidiebereOnongayaDanJonesWeiChenEugeneJKoaySomashekarKrishna
    World Journal of Gastroenterology 2022年6期

    Devarshi R Ardeshna,Troy Cao, Brandon Rodgers, Chidiebere Onongaya, Dan Jones, Wei Chen, Eugene JKoay, Somashekar G Krishna

    Abstract Pancreatic cystic lesions (PCLs) are becoming more prevalent due to more frequent abdominal imaging and the increasing age of the general population. It has become crucial to identify these PCLs and subsequently risk stratify them to guide management. Given the high morbidity associated with pancreatic surgery,only those PCLs at high risk for malignancy should undergo such treatment.However, current diagnostic testing is suboptimal at accurately diagnosing and risk stratifying PCLs. Therefore, research has focused on developing new techniques for differentiating mucinous from non-mucinous PCLs and identifying high risk lesions for malignancy. Cross sectional imaging radiomics can potentially improve the predictive accuracy of primary risk stratification of PCLs at the time of detection to guide invasive testing. While cyst fluid glucose has reemerged as a potential biomarker, cyst fluid molecular markers have improved accuracy for identifying specific types of PCLs. Endoscopic ultrasound guided approaches such as confocal laser endomicroscopy and through the needle microforceps biopsy have shown a good correlation with histopathological findings and are evolving techniques for identifying and risk stratifying PCLs.While most of these recent diagnostics are only practiced at selective tertiary care centers, they hold a promise that management of PCLs will only get better in the future.

    Key Words: Pancreatic cystic lesion; Intraductal papillary mucinous neoplasms; Mucinous cystic neoplasm; Microforceps biopsy; Radiomics; Confocal laser endomicroscopy

    INTRODUCTION

    Pancreatic cystic lesions (PCLs) are increasingly detected, largely due to advances in imaging techniques and the increasing age of the general population[1 ]. With prevalence estimated in the range of 4 %-14 % in the general population and increasing constantly, it has become essential to characterize and risk stratify these cysts to guide management[2 ]. Current guidelines for evaluating PCLs are limited to less than optimal diagnostic techniques, resulting in either missed detection of early cancer or surgical over-treatment (see Figure 1 ). Resection of PCLs should be extremely selective since pancreatic surgery generally has a 20 %-40 % morbidity rate and an approximate 2 % mortality rate[3 -5 ]. Therefore, research and utilization of safe and effective diagnostic modalities with high accuracy are needed to evaluate cysts and introduce properly timed interventions.

    Addressing this issue is especially relevant for intraductal papillary mucinous neoplasms (IPMNs), a type of PCL with one of the highest risks for malignancy. Of the two IPMN subtypes, main duct IPMNs are reported to have a risk from 38 % to 68 %and branch duct IPMNs from 12 % to 47 %[6 ]. Substantial research has addressed the use of consensus guidelines for evaluating IPMNs, but all mention that significant areas of improvement is imperative[7 -9 ].

    Current standards for the evaluation of cyst morphology include computed tomography (CT) scan, magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS). Fine needle aspiration (FNA) of cyst fluid for carcinoembryonic antigen (CEA) and cytology is performed during EUS. Considerable heterogeneity exists among the five widely used guidelines, which indicate a lack of standardization in diagnostic workups[7 -12 ]. In terms of the target population, American College of Gastroenterology and European guidelines include all PCLs, American College of Radiology guidelines focus on incidental PCLs, Fukuoka guidelines only focuses on IPMNs and American Gastroenterological Association (AGA) includes all PCLs except main-duct IPMNs. Guidelines differ in recommending evaluation with EUS and EUSFNA, and surgical resection. Multiple studies have compared some of these guidelines for identifying high-risk PCLs. Amongst patients who underwent surgery, the current guidelines directed clinical decision with an accuracy, sensitivity and specificity of 49 .6 %, 23 .5 %, 84 .3 % for 2015 AGA guidelines, 41 .2 %, 39 .7 %, 43 .1 % for revised Fukuoka guidelines and 58 %, 67 .7 %, 45 .1 % for 2018 European guidelines[13 ].

    Figure 1 Current standard of care diagnostic methods are suboptimal in the diagnosis of specific types of pancreatic cystic lesions and risk-stratification of mucinous cysts. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms, MCN:Mucinous cystic neoplasm, SPN: Solid pseudopapillary neoplasm, Cystic-NET: Cystic neuroendocrine tumors, SCA: Serous cystadenoma.

    A better understanding of investigational characteristics that lead to malignancy is necessary to improve existing criteria and accurately determine associated risks(Figure 1 ). While cyst fluid glucose has reemerged as a potential biomarker, novel techniques such as cyst fluid molecular analysis, EUS-guided needle-based confocal laser endomicroscopy (EUS-nCLE) and microforceps biopsy (EUS-MFB) have been introduced. The aim of this review is to provide an update of the recent literature in the management of PCLs with an emphasis on novel diagnostic methods.

    RADIOMICS

    Increasing prevalence of incidental PCLs has placed significant pressure on the necessity of discerning low-risk and high-risk lesions identified in radiological images.Radiomics is the analysis of mathematically derived textural features from crosssectional imaging studies. The features are generally beyond human visual perception.Using radiometric feature extraction tool, radiomics can quantify individual pixels and their associated gray-scale value from cross-sectional imaging in a temporal and spatial plane to create a cyst impression. While studies have varied in the extraction of radiometric data, these features can potentially risk stratify PCLs. Hence, radiomics can guide downstream invasive diagnostics.

    Studies in radiomics can be classified into two broad categories: (1 ) Differentiating types of PCLs, and (2 ) Risk stratification of IPMNs. Investigators have applied machine learning algorithms to radiomic features for automatic classification of PCLs.Some recent studies have evaluated nomograms and algorithms combining radiomics,cyst morphology, and clinical features. For differentiating PCLs, several investigations have demonstrated promising results. One of the first studies by Dmitrievet al[14 ],achieved a reasonable accuracy of 83 .6 % in discriminating PCL types into IPMNs,mucinous cystic neoplasms (MCNs), serous cystadenoma (SCAs) and solid neoplasms[14 ]. Their model had 93 .2 %-95 .9 % accuracy at predicting IPMNs. Subsequently, three investigations utilized CT-Scan radiomics to differentiate serous cystadenomas from other PCLs (area under the curve (AUC) 0 .77 -0 .99 , sensitivity 69 %-95 %, specificity 71 %-96 %)[15 -17 ]. In one of these studies, radiomics outperformed radiologic characteristics in differentiating MCNs and macrocystic SCAs; comparative diagnostic parameters included sensitivity (93 .6 % vs 74 .2 %), specificity (96 .2 % vs 80 .8 %) and accuracy (94 .7 % vs 77 .2 %), respectively[16 ]. Combining radiomics with radiological findings or clinical parameters significantly improved the accuracy to distinguish cyst types in comparison to radiomics alone (P< 0 .05 ) [16 ,18 ].

    Only a few studies have evaluated the role of radiomics in differentiating IPMNs with advanced neoplasia, from indolent lesions with low-grade dysplasia (Table 1 )[19 -23 ]. Most of the studies evaluating radiomics in IPMNs have used CT scans, and included patients with confirmed surgical histopathology as ground truth. A recent study by Cuiet al[24 ], presents the first publication where a radiomic signature incorporating 9 features was combined with clinical variables to predict high-grade dysplasia or adenocarcinoma (advanced neoplasia) in branch duct-IPMNs. Their predictive nomogram diagnosed advanced neoplasia with AUC values of 0 .903 (training cohort; sensitivity 95 %, specificity 73 %), and 0 .884 (one of two external validation cohorts; sensitivity 79 %, specificity 90 %)[24 ].

    Table 1 Summary of studies evaluating the role of radiomics in differentiating intraductal papillary mucinous neoplasms with advanced neoplasia

    HGD: High-grade dysplasia; LGD: Low-grade dysplasia; CECT: Contrast-enhanced computed tomography; MRI: Magnetic resonance imaging; mi-RNA:micro-RNA; DWI: Diffusion weighted imaging; AUC: Area under curve; SN: Sensitivity; SP: Specificity; NA: Not application.

    Thus, radiomics represents a promising non-invasive approach for the classification and risk stratification of PCLs and will favorably impact patient management.However, radiomics continues to be a novel concept and has been largely used to date in clinical trials at academic centers. While radiomics has demonstrated an immense potential for diagnosis, prognosis, and risk assessment in PCLs; there is a need for standardized protocols for image acquisition, segmentation, feature extraction, and analysis.

    TRADITIONAL DIAGNOSTIC APPROACHES USING BIOMARKERS

    Cyst fluid analysis

    CEA and amylase: Traditionally pancreatic cyst fluid is aspirated using EUS-FNA for biomarker and cytologic analysis. In early studies, cyst fluid CEA levels above 192 ng/mL was shown to correlate with mucinous PCL with 79 % (88 /111 ) accuracy (P<0 .0001 )[25 ]. However more recent studies, have estimated CEA sensitivity and specificity at 63 % and 88 %, respectively in differentiating mucinous from nonmucinous cysts[26 ]. This level of accuracy would result in misdiagnosis of 35 %-39 % of mucinous cysts. Additionally, CEA levels across sites are difficult to compare and levels have not been shown to correlate with PCL malignant potential[25 ,27 -29 ].Regarding amylase levels, a low cyst fluid amylase level has very high specificity for excluding pseudocyst. However, high amylase levels have been shown to have no diagnostic utility[26 ,30 ]. As a result, measuring amylase has fallen out of favor for the diagnosis of PCLs.

    Cytology: Cyst fluid analysis by cytology has been shown to lack sensitivity for the diagnosis of PCLs. A meta-analysis with 937 patients demonstrated cyst fluid cytology to have 63 % sensitivity and 88 % specificity for the diagnosis of PCL[31 ]. Another metaanalysis calculated cytology to have 51 % and 94 % sensitivity and specificity,respectively[32 ]. This lack of sensitivity results from cytology evaluations usually detecting only intact exfoliated cells that are typically few in number[25 ,33 ].Glucose:Intracystic glucose has good accuracy at differentiating mucinous and nonmucinous cysts but this economical diagnostic tool has not been used in routine clinical practice. However, recent prospective studies have provided improved and sustained evidence that cyst fluid glucose should be considered for standard of care evaluation of PCLs. Low intra-cystic glucose concentration is predictive of a mucinous cyst while high concentrations are consistent with non-mucinous cysts. In 2020 ,Ribaldoneet al[34 ] reported from 56 patients that intra-cystic glucose concentration <50 mg/dL had significantly better sensitivity than a CEA level > 192 ng/mL for diagnosing mucinous cysts (93 .6 % vs 54 .8 %; P = 0 .003 ). Both CEA and intra-cystic glucose had high specificity for diagnosing mucinous cysts (96 % vs 100 %; P = 1 ). They reported that intra-cystic glucose concentration of more than 50 mg/dL had higher sensitivity than CEA values of less than 5 ng/mL for diagnosing non-mucinous cysts(96 % vs 72 %, P = 0 .07 ).

    A meta-analysis of 7 studies encompassing 566 patients reported that lower (cut-off< 50 mg/dL) intra-cystic glucose concentration had a pooled sensitivity of 90 .1 %(95 %CI: 87 .2 -92 .5 ) and pooled specificity of 85 .3 % (95 %CI: 76 .8 -91 .1 ) when differentiating mucinous from non-mucinous cysts[35 ]. In a subset analysis, point-of-care glucometer measurements for intra-cystic glucose (3 studies) also revealed comparable pooled sensitivity of 89 .5 % (95 %CI: 85 .5 -92 .5 ; I2 = 0 ) and pooled specificity of 83 .9 %(95 %CI: 68 .5 -92 .6 ; I2 = 43 ) for the differentiation of PCLs[35 ]. A more recent (2021 )meta-analysis that included 8 studies with 609 PCLs showed pooled sensitivities for glucosevsCEA of 91 % (95 %CI: 88 -94 ) vs 56 % (95 %CI 46 -66 ) (comparativePvalue <0 .001 ), pooled specificities were 86 % (95 %CI: 81 -90 ) vs 96 % (95 %CI: 90 -99 ), P > 0 .05 ,respectively[36 ].

    Estimation of glucose levels is a low-cost diagnostic test that has repeatedly demonstrated better accuracy at differentiating mucinous and non-mucinous cyst.While not being definitive, cyst fluid glucose is a practical and economical diagnostic tool that can help in the differentiation of PCLs.

    Molecular markers: With the introduction of next-generation sequencing (NGS),diagnosis of PCLs with either small gene panels and whole exome NGS have been employed. This method allows assessment of intact cell and cell-free nucleic acid that has been shed into the cyst fluid. DNA mutations that are commonly associated with pancreatic adenocarcinoma (KRAS, CDKN2A, SMAD4 , PTEN, PIK3 CA, and TP53 ) may also be present in precursor PCLs, with the latter five associated with advanced neoplasia.

    Similar to radiomics, molecular analysis of cyst fluid can contribute to the classification of PCLs, and risk stratification of IPMNs. In a meta-analysis (6 studies, 785 PCLs), McCartyet al[37 ] reported that the dual presence ofKRASandGNASmutations detected mucinous PCLs with a sensitivity of 75 % (95 %CI: 58 -87 %), specificity of 99 %(95 %CI: 67 -100 %), and diagnostic accuracy of 97 % (95 %CI: 95 -98 %), respectively. For specifically diagnosing IPMNs, dualKRAS/GNASmutation had 94 % (95 %CI: 72 -99 %)sensitivity, 91 % (95 %CI: 72 -98 ; I2 = 89 .83 %) specificity and 97 % (95 %CI: 95 -98 %)accuracy, respectively. Recently, our group identified, for the first time, that uncommonBRAFmutations (and occasionalMAP2K1mutations) characterize a significant subset of IPMNs that lackKRASmutations, indicating that RAS-MAPK dysregulation is ubiquitous in these tumors[12 ]. In the same study, we showed 88 .5 %sensitivity, 100 % specificity, and 90 .3 % accuracy for NGS differentiation of PCLs[12 ].

    For the risk stratification of IPMNs, Singhiet al[38 ] used next-generation sequencing to evaluate DNA mutations associated with advanced neoplasia. In a subgroup analysis of 102 patients with histopathologic diagnosis, they reported that the presence of TP53 , PIK3 CA and/or PTEN mutation had 88 % (95 %CI: 62 -98 %) sensitivity and 95 % (95 %CI: 88 -98 %) specificity, respectively for diagnosing IPMNs with advanced neoplasia.

    Cyst fluid molecular analysis by next generation sequencing is superior to measuring cyst CEA levels with superior accuracy and the ability to provide risk stratification for IPMNs. However, it is selectively available and represents a logistical and financial barrier for universal adaptation.

    ADVANCED INTERVENTIONAL DIAGNOSTIC APPROACHES

    EUS-guided needle confocal laser endomicroscopy

    EUS-guided needle confocal laser endomicroscopy (nCLE) permits real-time microscopic imaging of intra-cystic epithelium within a single plane. It allows forinvivopathological analysis of PCLs. Early studies have established the characteristic features for IPMNs. Investigations by Napoleonet al[40 ] in the CONTACT study established defining criteria for MCNs, SCAs, and cystic neuroendocrine tumors[39 ,40 ]. In 2020 , the INDEX study provided further support for nCLE as a viable diagnostic tool by demonstrating high performance in differentiating PCLs amongst the highest number (n= 65 ) of patients with surgical histopathology[41 ]. For the differentiation of PCLs into mucinous and non-mucinous lesions, a recent meta-analysis with 7 studies and 324 patients reported a pooled sensitivity, specificity and accuracy of 85 % (95 %CI: 71 -93 %), 99 % (95 %CI: 90 -100 %) and 99 % (95 %CI: 98 -100 %),respectively. The pooled risk of post-procedure acute pancreatitis was 1 % (95 %CI: 0 -3 %)[42 ]. Another recent meta-analysis (10 studies, 536 patients) reported a pooled sensitivity, specificity, and accuracy of 82 .4 % (95 %CI: 74 .7 -90 .1 %), 96 .6 % (95 %CI: 94 .3 -99 %), and 88 .6 % (95 %CI: 83 .7 -93 .4 %), respectively, for the differentiation of mucinous from non-mucinous PCLs[43 ].

    In addition to the high accuracy of diagnosing IPMNs and other cysts, nCLE can potentially determine the risk for advanced neoplasia in PCLs. To detect advanced neoplasia in IPMNs, multiple nCLE imaging variables were identified in a post-hoc analysis of the INDEX study[44 ], Figure 2 . This study identified that the variables with the highest interobserver agreement were papillary epithelial thickness and darkness.Specifically, nCLE visualized papillary epithelial thickness (width ≥ 50 μm) had a sensitivity, specificity, and AUC of 87 .5 % (95 %CI: 62 %-99 %), 100 % (95 %CI: 69 %-100 %),and 0 .95 , respectively for the detection of advanced neoplasia. Also, estimation of the papillary epithelial darkness (cut-off ≤ 90 pixel intensity) revealed a sensitivity,specificity, and AUC of 87 .5 % (95 %CI: 62 %-99 %), 100 % (95 %CI: 69 %-100 %), and 0 .90 ,respectively[44 ]. Analogously for mucinous cysts, Feng et al[45 ] reported that nCLE pattern of “dark aggregates of neoplastic cells” correlated with the morphologic features of "irregular branching and budding" and was diagnostic of malignancy, with 75 % sensitivity, 100 % specificity and 94 % accuracy, respectively.

    However, potential limitations of nCLE include differences in interobserver interpretation of images and the tedious nature of manually determining papillary epithelial thickness and darkness. Both of these issues were addressed with the development of a machine learning artificial intelligence model that identified advanced neoplasia in IPMNs with a sensitivity (83 %) and specificity (88 %) well above the Fukuoka or AGA guidelines[46 ].

    Despite the growing evidence of nCLE as a viable diagnostic technique, its incorporation into standard clinical evaluation is lacking. The primary challenges include equipment costs, optimal training in image acquisition and interpretation, and prevention of adverse events higher than the standard EUS-FNA process.

    EUS guided MFB or EUS-through-the-needle biopsy

    This technique utilizes an EUS guided approach to pass a specialized device, the Moray micro forceps (Moray micro forceps, US Endoscopy, Mentor, Ohio, United States) through the 19 -gauge EUS needle to collect tissue sample from PCLs. Multiple recent studies have demonstrated an improved diagnostic yield and accuracy in the diagnosis of specific types of PCLs[47 ,48 ].

    Multiple meta-analyses have been published and the most recent studies include the following. Tacelliet al[49 ] (2020 ) included 9 studies with 454 patients and pooled technical success, histological accuracy and diagnostic yield for specific types of PCLs were 98 .5 % (95 %CI: 97 .3 %-99 .6 %), 86 .7 % (95 %CI: 80 .1 -93 .4 ) and 69 .5 % (95 %CI: 59 .2 -79 .7 %), respectively. Additionally sensitivity and specificity for diagnosis of mucinous PCLs were 88 .6 % and 94 .7 %, respectively. However, the overall complication rate was 8 .6 % (95 %CI: 4 .0 -13 .1 %) with studies reporting rates ranging from 1 %-23 %. Of the reported complications, 57 .1 % had self-limiting bleedings (most commonly intra-cystic bleeding), 24 .5 % had mild pancreatitis, 6 .1 % had infections and 14 .3 % had abdominal pain. Westerveldet al[50 ] analyzed 8 studies with 426 patients reporting similar results. The MFB approach had significantly higher diagnostic yield for specific cyst type compared to cytology (72 .5 %, 95 %CI: 60 .6 -83 .0 % vs 38 .1 %, 95 %CI: 18 .0 -60 .5 %).Additionally, MFB had significantly higher diagnostic yield for mucinous cyst compared to cytology (OR: 3 .86 ; 95 %CI: 2 .0 -7 .44 , I2 = 72 %). Overall MFB procedures had a 7 % complication rate with 5 % incidence of intra-cystic hemorrhage and 2 .3 % risk of acute pancreatitis. More importantly, in a subgroup analysis of 92 patients who had surgical resection of their PCLs, MFB findings had concordance of 82 .3 % (95 %CI: 71 .9 -90 .7 %) for specific cyst diagnosis. MFB findings for mucinous cysts had a sensitivity of 90 .1 % (95 %CI: 78 .4 -97 .6 %) and specificity of 94 % (95 %CI: 81 .5 -99 .7 %). Additionally,the concordance rate for histological grade of dysplasia was 75 .6 % (95 %CI: 62 .3 -86 .8 ).

    Figure 2 Features identified on endoscopic ultrasound guided needle confocal laser endomicroscopy. IPMN: Intraductal papillary mucinous neoplasms.

    In another meta-analysis that included patients with surgical histopathology as reference diagnosis, the pooled sensitivity and specificity for diagnosing mucinous PCL was 86 % (95 %CI: 62 -96 %) and specificity 95 % (95 %CI: 79 -99 %) respectively[51 ].For diagnosis of specific cyst type, the pooled sensitivity and specificity were 69 %(95 %CI: 50 -83 %) and specificity 47 % (95 %CI: 28 -68 %), respectively. The authors also grouped IPMNs and MCNs with advanced neoplasia, SPNs, and cystic neuroendocrine tumors as high-risk cysts. MFB demonstrated a pooled sensitivity and specificity of 78 % (95 %CI: 61 -89 %) and 99 % (95 %CI: 90 -99 %) respectively for diagnosis of a high-risk cyst.

    While MFB represents an excellent technique for acquisition of tissue and accurately diagnosing PCLs, the high rates of adverse events including acute pancreatitis and intra-cystic bleeding may deter clinicians from using this technique.

    Contrast-enhanced EUS

    EUS when combined with contrast enhancers allows detection of vascularity within PCLs. This allowed contrast-enhanced EUS (CE-EUS) to differentiate pseudocysts from true PCLs and identify mural nodules within PCLs. Despite early studies reporting no improvement over traditional EUS at differentiating PCLs[52 ], recent studies have reported higher diagnostic yield for PCLs using CE-EUS (96 % compared to 71 % for traditional EUS)[53 ]. CE-EUS detected small lesions initially missed on contrast-enhanced CT or EUS-FNA[54 ]. Recent literature on CE-EUS has reported higher accuracy at diagnosing PCLs compared to CT, MRI and traditional EUS[55 ].Despite these encouraging results, CE-EUS has not gained traction in clinical management of PCLs.

    CONCLUSION

    Future directions in the diagnosis of pancreatic cysts

    Reliable and accurate diagnosis of PCLs is a bottleneck for appropriate management of these lesions. Although, novel diagnostics have improved the diagnostic accuracy,there is still a dearth of prospective multicenter studies and a need to understand the complementary role of these tests. Radiomics, as a non-invasive tool has the potential for preliminary risk stratification of PCLs into low-and-high risk lesions (Figure 3 ). The technique holds a potential to allow clinicians to skip expensive and invasive diagnostic techniques on certain low risk PCLs.

    For low-risk PCLs, and when EUS-FNA is indicated, low-cost cyst fluid analysis with glucose, CEA, and cytology can guide management (Figure 3 ). If radiomics and EUS cyst morphology are indicative of a high-risk PCL, advanced diagnostics with cyst fluid molecular analysis, nCLE, or microforceps biopsy can be considered based on the center and endoscopists’ expertise. The rate of adverse events with microforceps biopsy needs to be considered when considering this test.

    Figure 3 Future directions of detection and risk stratification of pancreatic cystic lesion to guide clinical management. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms.

    Despite the availability of multiple diagnostic methods, the diagnosis and management of PCLs continues to be challenging. The more recent diagnostic modalities lack supportive larger multicenter data and there is need to demonstrate cost-effectiveness when compared to using suboptimal techniques and resultant unwarranted resection of otherwise benign or indolent PCLs. Apart from diagnosis,surveillance methods for low-risk lesions needs innovation as current tools are resource-consumptive.

    xxx大片免费视频| 一本一本综合久久| 免费在线观看成人毛片| 国产伦理片在线播放av一区| 国产亚洲5aaaaa淫片| 亚洲精品乱久久久久久| 性插视频无遮挡在线免费观看| 成人二区视频| 国产成人精品福利久久| 亚洲精品日韩av片在线观看| 青青草视频在线视频观看| 非洲黑人性xxxx精品又粗又长| 夜夜爽夜夜爽视频| 寂寞人妻少妇视频99o| av免费在线看不卡| 一本一本综合久久| 日韩电影二区| 亚洲精品自拍成人| 青青草视频在线视频观看| 韩国高清视频一区二区三区| 国产免费视频播放在线视频 | 69av精品久久久久久| 亚洲av.av天堂| 久久精品国产亚洲av天美| 男人狂女人下面高潮的视频| 亚洲最大成人手机在线| 能在线免费看毛片的网站| 丝袜美腿在线中文| 国产片特级美女逼逼视频| 非洲黑人性xxxx精品又粗又长| 干丝袜人妻中文字幕| 最近2019中文字幕mv第一页| 国产69精品久久久久777片| 建设人人有责人人尽责人人享有的 | h日本视频在线播放| 国产精品99久久久久久久久| 高清视频免费观看一区二区 | 国产一区二区亚洲精品在线观看| 免费大片18禁| 色播亚洲综合网| 美女xxoo啪啪120秒动态图| a级毛片免费高清观看在线播放| 久久6这里有精品| 少妇熟女欧美另类| 久久久久久久大尺度免费视频| 日本一本二区三区精品| 在线播放无遮挡| 黄色日韩在线| 日本免费在线观看一区| 中文天堂在线官网| 深夜a级毛片| 少妇丰满av| av又黄又爽大尺度在线免费看| eeuss影院久久| 热99在线观看视频| 亚洲国产欧美在线一区| av在线天堂中文字幕| 亚洲精品久久午夜乱码| 亚洲av男天堂| 国产男人的电影天堂91| 亚洲av福利一区| 男人和女人高潮做爰伦理| 精品久久久噜噜| 寂寞人妻少妇视频99o| 国产男人的电影天堂91| 久久人人爽人人片av| 在线播放无遮挡| 国产三级在线视频| 美女内射精品一级片tv| 亚洲图色成人| 精品不卡国产一区二区三区| 国产一区亚洲一区在线观看| 亚洲人与动物交配视频| 精品少妇黑人巨大在线播放| 国产一区二区在线观看日韩| 一区二区三区乱码不卡18| 丝袜喷水一区| 亚洲精品亚洲一区二区| av在线播放精品| 18禁动态无遮挡网站| 国产成人精品福利久久| 久久久久久久久久黄片| 国产老妇伦熟女老妇高清| 午夜免费观看性视频| 男女边摸边吃奶| 淫秽高清视频在线观看| 晚上一个人看的免费电影| 大香蕉久久网| 国产欧美另类精品又又久久亚洲欧美| 少妇人妻精品综合一区二区| 免费大片黄手机在线观看| 精品国产三级普通话版| 插阴视频在线观看视频| 午夜视频国产福利| 看非洲黑人一级黄片| 嫩草影院入口| 国产欧美日韩精品一区二区| 91av网一区二区| 免费观看无遮挡的男女| 又黄又爽又刺激的免费视频.| 三级国产精品欧美在线观看| 99九九线精品视频在线观看视频| 国产91av在线免费观看| 欧美区成人在线视频| 五月玫瑰六月丁香| 国产亚洲一区二区精品| 久久鲁丝午夜福利片| 国内揄拍国产精品人妻在线| 久久久久网色| 搞女人的毛片| 97超视频在线观看视频| 2021少妇久久久久久久久久久| 干丝袜人妻中文字幕| 国产精品国产三级国产av玫瑰| 亚洲成人精品中文字幕电影| 日韩伦理黄色片| 床上黄色一级片| 最后的刺客免费高清国语| 日韩亚洲欧美综合| a级毛色黄片| 亚洲精品中文字幕在线视频 | 日日干狠狠操夜夜爽| 亚洲av免费高清在线观看| 国产亚洲一区二区精品| 日韩视频在线欧美| 汤姆久久久久久久影院中文字幕 | 看黄色毛片网站| 亚洲成人精品中文字幕电影| 大香蕉97超碰在线| 内射极品少妇av片p| 久久久久久九九精品二区国产| 亚洲av成人av| 午夜激情福利司机影院| 免费大片黄手机在线观看| 亚洲综合色惰| 秋霞在线观看毛片| 国产老妇女一区| 高清av免费在线| 青春草国产在线视频| 少妇高潮的动态图| 精品久久久久久久久av| 蜜桃久久精品国产亚洲av| 国产精品久久久久久久电影| 欧美一区二区亚洲| 亚洲精品一区蜜桃| 在线观看av片永久免费下载| 国产精品久久视频播放| 18+在线观看网站| eeuss影院久久| 国产在视频线精品| 免费看不卡的av| 看非洲黑人一级黄片| 春色校园在线视频观看| 亚洲在久久综合| 亚洲av.av天堂| 国产黄色视频一区二区在线观看| 精品酒店卫生间| 国产欧美另类精品又又久久亚洲欧美| 99久国产av精品| 熟女电影av网| 搡老妇女老女人老熟妇| 精品久久久噜噜| 日本与韩国留学比较| 大片免费播放器 马上看| 成人综合一区亚洲| 亚洲熟女精品中文字幕| 久久久久精品性色| av福利片在线观看| 免费看美女性在线毛片视频| 成人综合一区亚洲| 久久这里只有精品中国| 国产视频内射| 在线天堂最新版资源| 国产高清国产精品国产三级 | 天堂俺去俺来也www色官网 | 少妇猛男粗大的猛烈进出视频 | 欧美精品一区二区大全| 天天躁日日操中文字幕| 尾随美女入室| 日日撸夜夜添| 亚洲精品456在线播放app| 国产高清不卡午夜福利| 18禁在线播放成人免费| 亚洲在线自拍视频| 黄片无遮挡物在线观看| 麻豆成人午夜福利视频| 欧美不卡视频在线免费观看| 搡老乐熟女国产| 色尼玛亚洲综合影院| 两个人的视频大全免费| 一区二区三区免费毛片| 国产伦一二天堂av在线观看| 美女黄网站色视频| 少妇人妻精品综合一区二区| 精品国产露脸久久av麻豆 | 色尼玛亚洲综合影院| 天天躁夜夜躁狠狠久久av| 亚洲国产精品成人综合色| 国产免费又黄又爽又色| 国产 一区精品| 最近手机中文字幕大全| 91精品一卡2卡3卡4卡| 成人国产麻豆网| 老司机影院成人| 亚洲在久久综合| 精品午夜福利在线看| 成人二区视频| 亚洲av国产av综合av卡| 2021少妇久久久久久久久久久| 久久久久久久久久成人| 国产国拍精品亚洲av在线观看| 99久国产av精品| 两个人的视频大全免费| 一个人观看的视频www高清免费观看| 国产淫语在线视频| 国产成人91sexporn| 三级国产精品片| 国产精品久久久久久久电影| 男女视频在线观看网站免费| 亚洲,欧美,日韩| 国产成人91sexporn| 最近的中文字幕免费完整| 少妇高潮的动态图| 免费大片18禁| 人人妻人人看人人澡| 国产伦精品一区二区三区视频9| 成人av在线播放网站| 欧美日本视频| 黑人高潮一二区| 成人二区视频| 国产极品天堂在线| 中文乱码字字幕精品一区二区三区 | eeuss影院久久| 国产老妇伦熟女老妇高清| 日韩国内少妇激情av| 精品久久久久久久久av| 国产成人a区在线观看| 精华霜和精华液先用哪个| 中文乱码字字幕精品一区二区三区 | 国产成年人精品一区二区| 亚洲精品456在线播放app| 边亲边吃奶的免费视频| 欧美成人一区二区免费高清观看| 少妇熟女aⅴ在线视频| 一级a做视频免费观看| 蜜桃久久精品国产亚洲av| 亚洲av国产av综合av卡| 精品人妻熟女av久视频| 国产精品一区二区性色av| 男女视频在线观看网站免费| 熟妇人妻久久中文字幕3abv| 日本猛色少妇xxxxx猛交久久| 高清毛片免费看| 日产精品乱码卡一卡2卡三| 午夜免费激情av| 亚洲欧美日韩东京热| 97在线视频观看| 又爽又黄a免费视频| 深夜a级毛片| 成人性生交大片免费视频hd| 一级毛片黄色毛片免费观看视频| 国产精品久久久久久av不卡| 看免费成人av毛片| 天美传媒精品一区二区| 亚洲国产日韩欧美精品在线观看| 国产精品一区二区三区四区久久| 午夜久久久久精精品| 精品久久久久久久久亚洲| 最近2019中文字幕mv第一页| 男的添女的下面高潮视频| 亚洲国产最新在线播放| 女人久久www免费人成看片| 综合色av麻豆| av专区在线播放| 日日撸夜夜添| 国产乱人偷精品视频| 91aial.com中文字幕在线观看| 简卡轻食公司| 国产女主播在线喷水免费视频网站 | 国产成人一区二区在线| 综合色av麻豆| 赤兔流量卡办理| 亚州av有码| 午夜精品国产一区二区电影 | 九九久久精品国产亚洲av麻豆| 久久99热6这里只有精品| 国产麻豆成人av免费视频| 日本免费在线观看一区| 亚洲va在线va天堂va国产| 少妇熟女aⅴ在线视频| 噜噜噜噜噜久久久久久91| 一级爰片在线观看| 国产欧美另类精品又又久久亚洲欧美| 伊人久久国产一区二区| 美女主播在线视频| 国产淫片久久久久久久久| 最近中文字幕2019免费版| 两个人视频免费观看高清| 日日摸夜夜添夜夜添av毛片| 中国国产av一级| 亚洲丝袜综合中文字幕| 国产国拍精品亚洲av在线观看| 国产大屁股一区二区在线视频| 少妇被粗大猛烈的视频| 亚洲精品国产av蜜桃| 人人妻人人澡欧美一区二区| 最近2019中文字幕mv第一页| 天天躁夜夜躁狠狠久久av| 在现免费观看毛片| 身体一侧抽搐| 午夜精品在线福利| 国产老妇女一区| 色播亚洲综合网| 亚洲欧美日韩东京热| 久久综合国产亚洲精品| 欧美人与善性xxx| 久久久精品欧美日韩精品| 可以在线观看毛片的网站| 97超视频在线观看视频| 国产成人a区在线观看| 亚洲av男天堂| 免费黄频网站在线观看国产| 亚洲av免费在线观看| 久久精品国产亚洲av天美| 看非洲黑人一级黄片| 国产一级毛片在线| 日本午夜av视频| 国产精品一二三区在线看| 午夜日本视频在线| 99热全是精品| 只有这里有精品99| 麻豆av噜噜一区二区三区| 亚洲精品视频女| 久久久久精品性色| 91午夜精品亚洲一区二区三区| 日本欧美国产在线视频| 人妻夜夜爽99麻豆av| 99久久精品国产国产毛片| 国产有黄有色有爽视频| 2021少妇久久久久久久久久久| 熟女电影av网| 99久国产av精品国产电影| 99视频精品全部免费 在线| 午夜福利在线观看吧| 99久久九九国产精品国产免费| 久久精品久久精品一区二区三区| 黄色一级大片看看| 色播亚洲综合网| 少妇高潮的动态图| 午夜福利在线观看吧| 人人妻人人澡人人爽人人夜夜 | 乱码一卡2卡4卡精品| 国产免费福利视频在线观看| 色视频www国产| 国产精品1区2区在线观看.| 99九九线精品视频在线观看视频| 色尼玛亚洲综合影院| 最近中文字幕2019免费版| 最近视频中文字幕2019在线8| 欧美成人午夜免费资源| 日韩av在线免费看完整版不卡| 国语对白做爰xxxⅹ性视频网站| 国产成人freesex在线| 成人特级av手机在线观看| 欧美极品一区二区三区四区| 成人毛片60女人毛片免费| 精品久久久久久久末码| 伦精品一区二区三区| 国产亚洲91精品色在线| 欧美极品一区二区三区四区| 亚洲精品日韩在线中文字幕| 久久久色成人| 波野结衣二区三区在线| 视频中文字幕在线观看| 99热这里只有是精品50| 亚洲欧美成人综合另类久久久| 最近2019中文字幕mv第一页| 天堂中文最新版在线下载 | 在线观看av片永久免费下载| 大片免费播放器 马上看| 小蜜桃在线观看免费完整版高清| 久久国产乱子免费精品| 美女cb高潮喷水在线观看| 97超碰精品成人国产| 日韩欧美三级三区| 联通29元200g的流量卡| 亚洲最大成人av| 久久亚洲国产成人精品v| av在线天堂中文字幕| 高清视频免费观看一区二区 | 精品国产露脸久久av麻豆 | av天堂中文字幕网| 亚洲四区av| 亚洲av日韩在线播放| 在线免费十八禁| 日韩一本色道免费dvd| 亚洲精品成人av观看孕妇| 国产av在哪里看| 久久99热6这里只有精品| 亚洲成人精品中文字幕电影| 精品久久久久久成人av| 丰满人妻一区二区三区视频av| 最近最新中文字幕大全电影3| 免费不卡的大黄色大毛片视频在线观看 | 国产午夜精品久久久久久一区二区三区| 成人鲁丝片一二三区免费| 国产真实伦视频高清在线观看| 国产精品蜜桃在线观看| 精品一区二区免费观看| 成人综合一区亚洲| 亚洲最大成人av| 搞女人的毛片| 午夜福利在线观看吧| 肉色欧美久久久久久久蜜桃 | 亚洲av中文字字幕乱码综合| 超碰av人人做人人爽久久| 日韩,欧美,国产一区二区三区| 亚洲国产精品成人综合色| 久久久久久久久久人人人人人人| 午夜精品在线福利| freevideosex欧美| 亚洲av不卡在线观看| 亚洲美女视频黄频| 国产色婷婷99| 搡老乐熟女国产| 久久精品国产亚洲av涩爱| 国精品久久久久久国模美| av福利片在线观看| 麻豆成人午夜福利视频| 国产精品福利在线免费观看| 九九爱精品视频在线观看| 亚洲综合色惰| av专区在线播放| 国产精品精品国产色婷婷| 不卡视频在线观看欧美| videossex国产| 午夜福利在线观看免费完整高清在| 国产老妇伦熟女老妇高清| 午夜日本视频在线| 成人亚洲精品av一区二区| 国产伦精品一区二区三区视频9| 国产高清三级在线| or卡值多少钱| 大香蕉久久网| 国内精品宾馆在线| 亚洲真实伦在线观看| 午夜精品国产一区二区电影 | 听说在线观看完整版免费高清| 精品少妇黑人巨大在线播放| 能在线免费看毛片的网站| 1000部很黄的大片| 色视频www国产| 亚洲欧洲国产日韩| 国产免费又黄又爽又色| 欧美性感艳星| 国产精品1区2区在线观看.| 毛片女人毛片| 汤姆久久久久久久影院中文字幕 | 2021天堂中文幕一二区在线观| 中文字幕免费在线视频6| 一级毛片 在线播放| 免费人成在线观看视频色| 噜噜噜噜噜久久久久久91| 久久久久国产网址| 亚洲四区av| 日日啪夜夜撸| 欧美高清性xxxxhd video| 五月玫瑰六月丁香| 亚洲性久久影院| 在线观看免费高清a一片| 肉色欧美久久久久久久蜜桃 | 亚洲人成网站在线观看播放| 久久97久久精品| 欧美日韩亚洲高清精品| 一级毛片 在线播放| 99久久精品一区二区三区| 日本免费a在线| 三级经典国产精品| 国产在线男女| 偷拍熟女少妇极品色| 国产精品一区二区在线观看99 | 国产精品1区2区在线观看.| 日韩亚洲欧美综合| 国产真实伦视频高清在线观看| 又爽又黄a免费视频| 久久久久久国产a免费观看| 十八禁网站网址无遮挡 | 2022亚洲国产成人精品| 精品久久久久久成人av| 日韩av免费高清视频| 搞女人的毛片| av卡一久久| 两个人的视频大全免费| 91精品国产九色| 色吧在线观看| 97超碰精品成人国产| 毛片一级片免费看久久久久| 男的添女的下面高潮视频| 久热久热在线精品观看| 五月玫瑰六月丁香| 内射极品少妇av片p| 亚洲精品国产av成人精品| 亚洲av中文av极速乱| 99热这里只有精品一区| 少妇的逼好多水| 亚洲欧美日韩东京热| 2021少妇久久久久久久久久久| 久久99精品国语久久久| 精品久久久久久久久久久久久| 久久精品综合一区二区三区| 国产成人精品福利久久| 成人av在线播放网站| 婷婷色综合大香蕉| 欧美97在线视频| 国产黄色小视频在线观看| 全区人妻精品视频| 国产69精品久久久久777片| 一级毛片 在线播放| 国产精品不卡视频一区二区| 97热精品久久久久久| 男女啪啪激烈高潮av片| av线在线观看网站| 久久久久久国产a免费观看| 99久久九九国产精品国产免费| 亚洲国产精品成人久久小说| 国产不卡一卡二| 国产探花在线观看一区二区| 久久6这里有精品| 亚洲精品aⅴ在线观看| 国产精品久久久久久久久免| 天堂√8在线中文| 特级一级黄色大片| 久久久色成人| 黄片wwwwww| 亚洲丝袜综合中文字幕| 卡戴珊不雅视频在线播放| 边亲边吃奶的免费视频| 精品99又大又爽又粗少妇毛片| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 内射极品少妇av片p| 亚洲最大成人手机在线| 亚洲精品成人久久久久久| 午夜精品一区二区三区免费看| 午夜亚洲福利在线播放| 国内精品美女久久久久久| 99久国产av精品| 高清av免费在线| 大香蕉久久网| 久久精品夜色国产| 亚洲av.av天堂| 国产午夜精品论理片| 禁无遮挡网站| 亚洲精品成人久久久久久| 成人一区二区视频在线观看| 久久韩国三级中文字幕| 亚洲精品视频女| 中文在线观看免费www的网站| 欧美性感艳星| 寂寞人妻少妇视频99o| 特大巨黑吊av在线直播| 精品久久国产蜜桃| 老司机影院毛片| 三级国产精品片| 亚洲精品色激情综合| 成人高潮视频无遮挡免费网站| 国产人妻一区二区三区在| 最新中文字幕久久久久| 国产精品人妻久久久久久| 插阴视频在线观看视频| 少妇人妻一区二区三区视频| 精品一区二区三卡| 欧美成人a在线观看| 日产精品乱码卡一卡2卡三| 真实男女啪啪啪动态图| 日本av手机在线免费观看| 亚洲av日韩在线播放| 亚洲人成网站在线播| 狂野欧美激情性xxxx在线观看| 国产熟女欧美一区二区| 极品教师在线视频| 一级毛片电影观看| 全区人妻精品视频| 女的被弄到高潮叫床怎么办| 一级毛片电影观看| 国产精品久久久久久久电影| 晚上一个人看的免费电影| 欧美另类一区| 在线a可以看的网站| 又爽又黄无遮挡网站| 国产成人福利小说| 色网站视频免费| 亚洲精品中文字幕在线视频 | 国产成人a区在线观看| 日日摸夜夜添夜夜爱| 婷婷色麻豆天堂久久| 国产亚洲av片在线观看秒播厂 | 国产成人午夜福利电影在线观看| 久久久久九九精品影院| 91av网一区二区| 小蜜桃在线观看免费完整版高清| 午夜免费激情av| 看非洲黑人一级黄片| 97超碰精品成人国产| 国产精品熟女久久久久浪| 在线观看一区二区三区| 国产成人午夜福利电影在线观看| 国产亚洲av嫩草精品影院| 国产不卡一卡二| 中文资源天堂在线| 亚洲国产精品成人久久小说| 女人精品久久久久毛片| 久久久久精品人妻al黑| 最近的中文字幕免费完整| 可以免费在线观看a视频的电影网站 | 狠狠婷婷综合久久久久久88av|